We are pleased to announce that our consultant, Dr. Rebecca Arend of the University of Alabama at Birmingham (UAB), currently has two clinical trials that are dedicated to the treatment of carcinosarcoma patients!
This trial is tailored specifically for recurrent carcinosarcoma patients.
This clinical trial is being conducted at the University of Alabama at Birmingham.
This clinical trial is being conducted at 17 locations in the US, including the University of Alabama, Birmingham, AL.
Dr. Rebecca Arend, MD is the Principal Investigator for this multi-site study.
For more information on clinical trials, please click here.
Clinical trials are currently being offered at the University of Arkansas for Medical Sciences (UAMS). Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of BLU-222 as a Single… Read More »
Clinical trials are currently being offered at the University of Alabama at Birmingham. Immunotherapy has gained a significant amount of attention recently, but its efficacy as a single agent in… Read More »
Clinical trials are currently being offered at Medical University of South Carolina (MUSC) Health Care in Charleston SC. A Phase II/III Study of Paciltaxel/Carboplatin alone, or combined with either Trastuzumab… Read More »
